Researchers have shown that mucosal immunity can be improved by administering booster vaccines directly into the lungs, offering a potential way to prevent COVID-19 in humans. A study demonstrated near complete protection from COVID-19 in macaques with an inhaled vaccine, emphasizing the importance of developing vaccines that block infection and the increased immune cell activity.
Boosting mucosal immunity through direct administration of vaccines to the lungs can significantly improve immune responses and prevent COVID-19 infection.
Delivering vaccines through inhalation, specifically via the intertracheal route, results in near complete protection against SARS-CoV-2 infection and increases antibody and T cell responses.
Deep dives
Boosting mucosal immunity could help prevent Covid infection
A new research study published in Nature suggests that boosting mucosal immunity could play a key role in preventing Covid infection. While current vaccines offer protection against severe disease, they do not provide strong protection against acquiring the infection or mild symptomatic infection. The study examined the effectiveness of administering vaccine boosts directly to different parts of the body, such as the lungs, to enhance mucosal immunity. The researchers found that intramuscular boosting had only modest effects on mucosal antibody and T cell responses. However, direct administration of the vaccine to the lungs showed a significant improvement in mucosal immune responses, resulting in near complete protection against infection.
Administering vaccines through inhalation shows promise
The study also explored the possibility of delivering vaccines through inhalation, which was found to be safe and effective in raising potent mucosal immunity. Researchers administered the vaccine to macaques via the intertracheal route, resulting in near complete protection against SARS-CoV-2 infection. This method led to increased immune cell activity and sustained activation of inflammatory responses in the lungs, resulting in profound increases in antibody and T cell responses. The findings suggest that mucosal routes of vaccination, particularly through inhalation, should be further explored and utilized to achieve high levels of mucosal immunity.
Current COVID-19 vaccines offer great protection from serious illness, but they don't prevent people from becoming infected in the first place. Because of this, researchers have been searching for ways to boost mucosal immunity — the immune response on mucosal surfaces — as this is where the virus is first encountered by the body. Now a team have shown that mucosal immunity can be improved enough to block infection in rhesus macaques by administering booster vaccines directly into their lungs, through inhalation. They hope this could offer a way to stop humans getting COVID-19 in the future.